All things are born at the right time; share the same virtue with the son, and win-win with the son.

--Inscription

Recently, Tianjushi Engineering Technology Group Co., Ltd. (hereinafter referred to as "Tianjushi Group") and CB Consultancy AG (hereinafter referred to as "CBC") reached an in-depth strategic cooperation agreement in the form of equity acquisition. CBC will serve as the conceptual design team for the general contracting business of Biomedical Engineering and become the leading force in the overall solution of Biomedical Engineering. At the same time, Mr. Christian Bachofen, the founder of CBC, will serve as the Chief Technology Officer of Biomedicine of Tianjushi Group. With his rich industry experience, he will lead and promote the rapid development of Tianjushi Group in the field of biomedical engineering EPC.

CB Consultancy AG is a Swiss consulting company providing professional design, construction project management and industrial plant operation for global pharmaceutical companies. The company focuses on biopharmaceutical and high-end preparation projects, and has strong design strength in projects such as monoclonal antibodies, proteins, vaccines and new crown vaccines, and the main designers have more than 20 years of experience in pharmaceutical plant design, engineering planning and consulting. Experience. CBC's business covers Switzerland, Europe and Asia. So far, it has served many large international biopharmaceutical companies such as Johnson & Johnson, Roche, Novartis, and has been rooted in the Chinese market for more than ten years. It has also cooperated with Zhongsheng Group, BeiGene, Luye Pharma and other well-known pharmaceutical companies have long-term friendly cooperation and are an international leading concept design and consulting service company. Carry out design consulting work such as plant area planning, conceptual design, basic design, and WHO pre-certification in China.

Mr. Christian Bachofen is an internationally renowned expert in biomedical design and planning, the founder and chief designer of CB Consultancy AG, and the chief technology officer of Biomedicine of Tianjushi Group.

Mr. Christian has extensive experience in the planning and design of pharmaceutical plant facilities, GMP clean room and HVAC system design, pharmaceutical water system design, and quality management systems. As the project leader, he has participated in a number of internationally renowned biopharmaceutical design projects, including Johnson & Johnson's freeze-dried antibody production plant and monoclonal antibody-vial dispensing line design project, Novartis Pharmaceuticals R&D Park office building and R&D laboratory building design Project, BeiGene Suzhou pilot production workshop and Guangzhou commercial production workshop design project and Zhongsheng Group's new crown vaccine production workshop and many other projects.

Tianjushi Group is a well-known general contracting service provider for large-scale pharmaceutical, environmental protection and metallurgical project construction in China. General contracting of patent medicine engineering, general contracting of medical device engineering, general contracting of food and health engineering, general contracting of environmental protection technology and engineering, general contracting of metallurgical engineering, automation information engineering, and continuous consumption equipment. In the course of more than 20 years of development, Tianjushi has served more than 200 well-known pharmaceutical companies, including more than 50 of the top 100 pharmaceutical companies, and participated in the construction of nearly 100 pharmaceutical factories that meet the requirements of China's new GMP, FDA and EMA. , has been in the field of macromolecular biological drugs and highly active products, especially in the field of new biological preparations such as monoclonal antibodies, vaccines, insulin, cell therapy, gene therapy, etc. There are industry-representative cases.

This strategic cooperation with CBC has greatly enhanced the engineering and technical strength of Tianjushi Group in the field of biomedicine. Mr. Christian's rich experience in the field of biopharmaceutical engineering and international leading design ideas will help Tianjushi Group in biomedical engineering. A new chapter begins in the EPC field. In the future, Tianjushi Group will also give full play to the advantages of high-quality design and engineering resources including Mr. Christian and CBC, provide customers with higher-quality EPC turnkey projects, and help the rapid development of China's biopharmaceutical industry.